The high-activity Notch1 activation-dependent reporter knock-in allele, N1IP::CreHI, has the endogenous Notch1 intracellular domain (NICD1) replaced with a nuclear-localized Cre recombinase. Compared to N1IP::CreLO, this N1IP::CreHI allele has significantly improved sensitivity with five- to ten-fold increase in Cre activity. This improved sensitivity allows users to label cells experiencing moderate-to-lower Notch activation thresholds; including most cells/tissues known to utilize Notch1 during their development and/or maintenance.
Raphael Kopan, Cincinnati Children's Hospital Medical Center
Genetic Background | Generation |
---|---|
|
Allele Type | Gene Symbol | Gene Name |
---|---|---|
Targeted (Recombinase-expressing) | Notch1 | notch 1 |
The Notch1 activity-trap knock-in allele, N1IP::CreHI, has the endogenous Notch1 intracellular domain (NICD1) replaced by a Cre recombinase with nuclear localization signal. Like endogenous Notch1, the Notch1-Cre fusion protein is expressed on the cell membrane and its extracellular domain binds Notch ligands (-Delta, Serrate and Lag-2), but proteolytic cleavage of the transmembrane domain tether results in release of nuclear-localized Cre rather than NICD1. Cre then enters the nucleus, where it results in the excision of floxed sequences. If a Cre-dependent reporter is present, Cre recombinase activity will 'trap' the cells and permanently mark its descendent lineage independently of any further Notch1 activation. Specific cell types are described below.
Heterozygous mice are viable and fertile with no gross phenotypic abnormalities. Homozygotes die at embryonic day 9.5 (E9.5).
The Notch1 activation-dependent reporter knock-in alleles, N1IP::CreLO (Stock No. 006953), N1IP::CreERT2 (Stock No. 027235) and N1IP::CreHI (Stock No. 027234) are compared below.
N1IP::CreLO (and N1IP::CreERT2 in the presence of tamoxifen) is relatively insensitive and seems to predominantly 'trap' cells in which moderate-to-high levels of sustained Notch activity or repeated activation cycles are known to occur (e.g., endothelium), while missing cells in many tissues known to rely on Notch1 activity (e.g., the hematopoietic system). The donating investigator speculates these differences could be attributed to the reduced transcript stability of the NICD (due to the insertion of 6xMyc-tags at the C-terminus of the nuclear-localized Cre recombinase). Also, in some tissues, sequences required for proper membrane trafficking of Notch may have been lost when NICD1 was replaced with Cre recombinase.
The N1IP::CreHI allele lacks the C-terminal 6xMyc-tag and has one more additional polyadenylation signal following the nuclear-localized Cre recombinase. These improvements restore the Cre recombinase C-terminus and increase transcript stability two-fold, respectively; resulting in a cumulative five- to ten-fold increase in Cre activity. The resulting Notch1-Cre fusion protein is cleaved as efficiently as endogenous Notch1, and has significantly improved sensitivity compared to N1IP::CreLO. This improved sensitivity allows users to 'trap' cells experiencing moderate-to-lower Notch activation thresholds; including most cells/tissues known to utilize Notch1 during their development and/or maintenance.
The high-activity Notch intramembrane proteolysis-Cre knock-in allele (Notch1::CreHI, N1::CreHI, or N1IP::CreHI) was designed by Dr. Raphael Kopan (while at Washington University School of Medicine, St. Louis). First, the targeting construct for Notch1::CreLO (Stock No. 006953) was modified to remove the C-terminal 6xMyc epitope tag (restoring the original C-terminus), to add a third SV40 polyadenylation signal following the Cre recombinase sequence (to match the number of polyadenylation signals in wildtype Notch1 and to improve mRNA stability), and to introduce a single nucleotide variation in exon 28 to facilitate genotyping (C5178A; corresponding to a silent mutation at the third position for L1726). The final construct was designed to replace Notch1 exons 29-34 (encoding the intracellular domain) with a Cre recombinase sequence and nuclear localization signal, followed immediately downstream by a 3xSV40 polyadenylation sequence, and frt-flanked Pgk1/EM7 promoter-driven neomycin selection cassette. The construct was electroporated into 129X1/SvJ-derived SCC10 embryonic stem (ES) cells. Correctly targeted ES cells were injected into blastocysts to generate chimeric mice. Animals that transmitted the N1IP::CreHI allele through the germ line were obtained.
Mice were bred with C57BL/6N-congenic Flp-deleter mice (Stock No. 019100) to remove the selection cassette. After this, N1IP::CreHI mice were bred to remove the Flp-deleter transgene.
At some point, N1IP::CreHI mice were also bred with C57BL/6-congenic R26-LSL-lacZ reporter mice (Stock No. 003474) and
C57BL/6J-congenic Ai3(RCL-EYFP) reporter mice (Stock No. 007903). The R26-LSL-lacZ and Ai3(RCL-EYFP) alleles were later bred away.
N1IP::CreHI mice on a mixed C57BL/6;129SV;CD1 genetic background were sent to The Jackson Laboratory in 2015. Upon arrival, males were used to cryopreserve sperm. To establish the living N1IP::CreHI mouse colony, an aliquot of the frozen sperm was used to fertilize oocytes from C57BL/6J inbred females (Stock No. 000664).
Expressed Gene | cre, cre recombinase, bacteriophage P1 |
---|---|
Site of Expression | Endothelial cells. |
Allele Name | targeted mutation 4, Raphael Kopan |
---|---|
Allele Type | Targeted (Recombinase-expressing) |
Allele Synonym(s) | N1::Crehi; NIP::CreHI; Notch1::creHi |
Gene Symbol and Name | Notch1, notch 1 |
Gene Synonym(s) | |
Expressed Gene | cre, cre recombinase, bacteriophage P1 |
Site of Expression | Endothelial cells. |
Strain of Origin | 129X1/SvJ |
Chromosome | 2 |
Molecular Note | The Notch1 intracellular domain (IC) is replaced by the cre recombinase sequence and includes the SV40 3' UTR polyA signal while introducing a single nucleotide variation (SNV) at C5178A to facilitate genotyping. This allele does not have the 6xMyc tag present in the Notch1tm3(cre)Rko allele, and displays enhanced activity relative to that allele. |
When maintaining a live colony, heterozygous mice are bred to wildtype mice from the colony. Homozygotes die in utero.
When using the N1IP::CreHI mouse strain in a publication, please cite the originating article(s) and include JAX stock #027234 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Heterozygous or wildtype for Notch1<tm4(cre)Rko> |
Frozen Mouse Embryo | STOCK Notch1<tm4(cre)Rko>/J | $2595.00 |
Frozen Mouse Embryo | STOCK Notch1<tm4(cre)Rko>/J | $2595.00 |
Frozen Mouse Embryo | STOCK Notch1<tm4(cre)Rko>/J | $3373.50 |
Frozen Mouse Embryo | STOCK Notch1<tm4(cre)Rko>/J | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.